Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics
Open Access
- 22 September 2013
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 13 (1) , 58
- https://doi.org/10.1186/1471-2466-13-58
Abstract
It has been suggested that smoking asthmatics benefit less from corticosteroid treatment than never-smoking asthmatics. We investigated differences in blood and sputum inflammatory profiles between ex-, current-, and never-smokers and assessed their ICS treatment response after 2-week and 1-year treatment.Keywords
This publication has 35 references indexed in Scilit:
- Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking statusRespiratory Medicine, 2012
- Increased levels of angiopoietin‐2 in induced sputum from smoking asthmatic patientsClinical and Experimental Allergy, 2009
- Smoking Affects Eotaxin Levels in Asthma PatientsJournal of Asthma, 2009
- Smoking Affects Response to Inhaled Corticosteroids or Leukotriene Receptor Antagonists in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophagesThe FASEB Journal, 2001
- Relationships of active smoking to asthma and asthma severity in the EGEA studyEuropean Respiratory Journal, 2000
- The Dominant Negative Activity of the Human Glucocorticoid Receptor β IsoformJournal of Biological Chemistry, 1999
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Bronchial reactivity to inhaled histamine: a method and clinical surveyClinical and Experimental Allergy, 1977